Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weishi Cheng

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Hematology & Oncology|July 27, 2024
Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancerWeishi Cheng, Kai Kang, Ailin Zhao, et al.
BMC Pediatrics|March 12, 2025
Clinical features, treatment and prognosis of primary pulmonary rhabdomyosarcoma: A systemic reviewYinjie Tao, Weishi Cheng, Hongnan Zhen, et al.
The Oncologist|April 12, 2025
Epidemiology characteristics and clinical outcomes of composite Hodgkin lymphoma and diffuse large B-cell lymphoma using machine learningAilin Zhao, Xu Sun, Weishi Cheng, et al.
Discover Oncology|February 12, 2025
A deep learning model to predict dose distributions for breast cancer radiotherapyXiaorong Hou, Weishi Cheng, Jing Shen, et al.
Technology in Cancer Research & Treatment|July 7, 2025
Cervical Cancer in Pregnancy: A 10-Year Retrospective Analysis of Clinical Management and Future PerspectivesYuliang Sun, Weishi Cheng, Jing Shen, et al.
Annals of Hematology|June 19, 2025
Epidemiologic trends for pediatric Hodgkin and non-Hodgkin lymphomas: a U.S. population-based studyWeishi Cheng, Xu Sun, Shijie Yang, et al.
Cancer Control : Journal of the Moffitt Cancer Center|April 12, 2025
Moderate-Hypofractionated Radical Radiotherapy for Early-Stage Prostate Cancer: A Propensity Score Matching Analysis Comparing Dose Fractionation PatternsYinjie Tao, Weishi Cheng, Hongnan Zhen, et al.
Biomarker Research|March 19, 2025
Dynamic changes of bone microarchitecture and volumetric mineral density assessed by HR-pQCT in patients with cervical cancer after concurrent chemoradiotherapy: a prospective studyWeishi Cheng, Yijun Wu, Jing Shen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Hematology & Oncology|July 27, 2024
Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancerWeishi Cheng, Kai Kang, Ailin Zhao, et al.
BMC Pediatrics|March 12, 2025
Clinical features, treatment and prognosis of primary pulmonary rhabdomyosarcoma: A systemic reviewYinjie Tao, Weishi Cheng, Hongnan Zhen, et al.
The Oncologist|April 12, 2025
Epidemiology characteristics and clinical outcomes of composite Hodgkin lymphoma and diffuse large B-cell lymphoma using machine learningAilin Zhao, Xu Sun, Weishi Cheng, et al.
Discover Oncology|February 12, 2025
A deep learning model to predict dose distributions for breast cancer radiotherapyXiaorong Hou, Weishi Cheng, Jing Shen, et al.
Technology in Cancer Research & Treatment|July 7, 2025
Cervical Cancer in Pregnancy: A 10-Year Retrospective Analysis of Clinical Management and Future PerspectivesYuliang Sun, Weishi Cheng, Jing Shen, et al.
Annals of Hematology|June 19, 2025
Epidemiologic trends for pediatric Hodgkin and non-Hodgkin lymphomas: a U.S. population-based studyWeishi Cheng, Xu Sun, Shijie Yang, et al.
Cancer Control : Journal of the Moffitt Cancer Center|April 12, 2025
Moderate-Hypofractionated Radical Radiotherapy for Early-Stage Prostate Cancer: A Propensity Score Matching Analysis Comparing Dose Fractionation PatternsYinjie Tao, Weishi Cheng, Hongnan Zhen, et al.
Biomarker Research|March 19, 2025
Dynamic changes of bone microarchitecture and volumetric mineral density assessed by HR-pQCT in patients with cervical cancer after concurrent chemoradiotherapy: a prospective studyWeishi Cheng, Yijun Wu, Jing Shen, et al.
Pageof 1